[Apoptosis and inflammation in bronchial asthma].
Nevzorova
V A
VA
Suvorenko
T N
TN
Konovalova
E N
EN
D000893:Anti-Inflammatory Agents / Q000494:pharmacology / Q000627:therapeutic use; D017209:Apoptosis / Q000187:drug effects; D001249:Asthma / Q000276:immunology* / Q000378:metabolism / Q000473:pathology*; D001993:Bronchodilator Agents / Q000494:pharmacology / Q000627:therapeutic use; D004804:Eosinophils / Q000473:pathology; D005938:Glucocorticoids / Q000494:pharmacology / Q000627:therapeutic use; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000378:metabolism; D006801:Humans; D007249:Inflammation / Q000378:metabolism*; D007371:Interferon-gamma / Q000378:metabolism; D008264:Macrophages / Q000473:pathology; D009569:Nitric Oxide / Q000378:metabolism; D010726:Phosphodiesterase Inhibitors / Q000494:pharmacology / Q000627:therapeutic use; D010766:Phosphorylation; D019253:Proto-Oncogene Proteins c-bcl-2 / Q000037:antagonists & inhibitors / Q000378:metabolism; D013109:Sphingomyelins / Q000378:metabolism; D013256:Steroids; D013601:T-Lymphocytes / Q000473:pathology; D013806:Theophylline / Q000494:pharmacology / Q000627:therapeutic use; D019014:fas Receptor / Q000378:metabolism
D000893:Anti-Inflammatory Agents; D001993:Bronchodilator Agents; D005938:Glucocorticoids; D010726:Phosphodiesterase Inhibitors; D019253:Proto-Oncogene Proteins c-bcl-2; D013109:Sphingomyelins; D013256:Steroids; D019014:fas Receptor; D009569:Nitric Oxide; D007371:Interferon-gamma; D016178:Granulocyte-Macrophage Colony-Stimulating Factor; D013806:Theophylline